How valuable can proteogenomics be in clinical breast cancer research?
Sign Up to like & getrecommendations! Published in 2023 at "Expert Review of Proteomics"
DOI: 10.1080/14789450.2023.2203390
Abstract: Nearly, 45,000 women are estimated to die from breast cancer in 2022 in the US alone [1,2]. Breast cancer displays high heterogeneity with a wide spectrum of clinical, pathological, and molecular features, which makes it… read more here.
Keywords: proteogenomics clinical; valuable proteogenomics; breast; clinical breast ... See more keywords